BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 27139916)

  • 1. Impact of long-term gastric acid suppression on spontaneous bacterial peritonitis in patients with advanced decompensated liver cirrhosis.
    Huang KW; Kuan YC; Luo JC; Lin CL; Liang JA; Kao CH
    Eur J Intern Med; 2016 Jul; 32():91-5. PubMed ID: 27139916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of spontaneous bacterial peritonitis associated with gastric Acid suppression.
    Chang SS; Lai CC; Lee MG; Lee YC; Tsai YW; Hsu WT; Lee CC
    Medicine (Baltimore); 2015 Jun; 94(22):e944. PubMed ID: 26039135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites.
    Bajaj JS; Zadvornova Y; Heuman DM; Hafeezullah M; Hoffmann RG; Sanyal AJ; Saeian K
    Am J Gastroenterol; 2009 May; 104(5):1130-4. PubMed ID: 19337238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased rate of spontaneous bacterial peritonitis among cirrhotic patients receiving pharmacologic acid suppression.
    Goel GA; Deshpande A; Lopez R; Hall GS; van Duin D; Carey WD
    Clin Gastroenterol Hepatol; 2012 Apr; 10(4):422-7. PubMed ID: 22155557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton pump inhibitor use significantly increases the risk of spontaneous bacterial peritonitis in 1965 patients with cirrhosis and ascites: a propensity score matched cohort study.
    Min YW; Lim KS; Min BH; Gwak GY; Paik YH; Choi MS; Lee JH; Kim JJ; Koh KC; Paik SW; Yoo BC; Rhee PL
    Aliment Pharmacol Ther; 2014 Sep; 40(6):695-704. PubMed ID: 25078671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton pump inhibitor intake neither predisposes to spontaneous bacterial peritonitis or other infections nor increases mortality in patients with cirrhosis and ascites.
    Mandorfer M; Bota S; Schwabl P; Bucsics T; Pfisterer N; Summereder C; Hagmann M; Blacky A; Ferlitsch A; Sieghart W; Trauner M; Peck-Radosavljevic M; Reiberger T
    PLoS One; 2014; 9(11):e110503. PubMed ID: 25369194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acid-suppressive therapy is associated with spontaneous bacterial peritonitis in cirrhotic patients: a meta-analysis.
    Deshpande A; Pasupuleti V; Thota P; Pant C; Mapara S; Hassan S; Rolston DD; Sferra TJ; Hernandez AV
    J Gastroenterol Hepatol; 2013 Feb; 28(2):235-42. PubMed ID: 23190338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic review and meta-analysis of the possible association between pharmacological gastric acid suppression and spontaneous bacterial peritonitis.
    Khan MA; Kamal S; Khan S; Lee WM; Howden CW
    Eur J Gastroenterol Hepatol; 2015 Nov; 27(11):1327-36. PubMed ID: 26313401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between acid suppressive therapy and spontaneous bacterial peritonitis in cirrhotic patients with ascites.
    Choi EJ; Lee HJ; Kim KO; Lee SH; Eun JR; Jang BI; Kim TN
    Scand J Gastroenterol; 2011 May; 46(5):616-20. PubMed ID: 21275825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton pump inhibitor therapy does not increase the incidence of spontaneous bacterial peritonitis in cirrhosis: a multicenter prospective study.
    Terg R; Casciato P; Garbe C; Cartier M; Stieben T; Mendizabal M; Niveyro C; Benavides J; Marino M; Colombato L; Berbara D; Silva M; Salgado P; Barreyro F; Fassio E; Gadano A;
    J Hepatol; 2015 May; 62(5):1056-60. PubMed ID: 25481567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton pump inhibitors do not increase the risk for recurrent spontaneous bacterial peritonitis in patients with cirrhosis.
    Kim JH; Lim KS; Min YW; Lee H; Min BH; Rhee PL; Kim JJ; Koh KC; Paik SW
    J Gastroenterol Hepatol; 2017 May; 32(5):1064-1070. PubMed ID: 28449345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton pump inhibitors are associated with a high rate of serious infections in veterans with decompensated cirrhosis.
    Bajaj JS; Ratliff SM; Heuman DM; Lapane KL
    Aliment Pharmacol Ther; 2012 Nov; 36(9):866-74. PubMed ID: 22966967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton pump inhibitor therapy and its association with spontaneous bacterial peritonitis incidence and mortality: A meta-analysis.
    Yu T; Tang Y; Jiang L; Zheng Y; Xiong W; Lin L
    Dig Liver Dis; 2016 Apr; 48(4):353-9. PubMed ID: 26795544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton pump inhibitor use increases mortality and hepatic decompensation in liver cirrhosis.
    De Roza MA; Kai L; Kam JW; Chan YH; Kwek A; Ang TL; Hsiang JC
    World J Gastroenterol; 2019 Sep; 25(33):4933-4944. PubMed ID: 31543684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between proton pump inhibitor use and spontaneous bacterial peritonitis in cirrhotic patients with ascites.
    Ratelle M; Perreault S; Villeneuve JP; Tremblay L
    Can J Gastroenterol Hepatol; 2014 Jun; 28(6):330-4. PubMed ID: 24945188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality associated with proton pump inhibitors in cirrhotic patients with spontaneous bacterial peritonitis.
    Kwon JH; Koh SJ; Kim W; Jung YJ; Kim JW; Kim BG; Lee KL; Im JP; Kim YJ; Kim JS; Yoon JH; Lee HS; Jung HC
    J Gastroenterol Hepatol; 2014 Apr; 29(4):775-81. PubMed ID: 24219827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between Proton Pump Inhibitor Therapy and Spontaneous Bacterial Peritonitis Occurrence in Cirrhotic Patients: A Clinical Review.
    Zhang M; Liu W; Xu X; Chen T; Qi JY
    Curr Med Sci; 2022 Aug; 42(4):673-680. PubMed ID: 35870102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton pump inhibitor use is associated with spontaneous bacterial peritonitis in patients with liver cirrhosis.
    Miura K; Tanaka A; Yamamoto T; Adachi M; Takikawa H
    Intern Med; 2014; 53(10):1037-42. PubMed ID: 24827481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors predicting the recurrence of spontaneous bacterial peritonitis in patients with cirrhosis.
    Jamil S; Ahmed S; Memon A; Masood S; Ali Shah SH; Hamid SS; Wasim Jafri SM
    J Coll Physicians Surg Pak; 2011 Jul; 21(7):407-10. PubMed ID: 21777528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Proton Pump Inhibitors vs Histamine 2 Receptor Antagonists for the Risk of Gastric Cancer: Population-Based Cohort Study.
    Shin GY; Park JM; Hong J; Cho YK; Yim HW; Choi MG
    Am J Gastroenterol; 2021 Jun; 116(6):1211-1219. PubMed ID: 34074826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.